Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Based in Norway, Lifecare AS is dedicated to the research and advancement of medical sensor technology for health tracking. A key innovation is Sencell, a compact sensor designed specifically for continuously monitoring glucose levels in diabetic patients. The company, which has its corporate headquarters in Bergen, Norway, commenced operations in 2006.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. In particular, the stock is 'cheap' on EV/EBITDA.
Target Price
The average target price of LIFE.OL is 0.40 and suggests 6.87% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation t